Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
88
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis

Wenshan Lin1 Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People’s Republic of China
,
Hong-Yan Li2 Department of Nephrology, Huadu District People’s Hospital of Guangzhou, Southern Medical University, Guangzhou, People’s Republic of China
,
Shujun Lin1 Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People’s Republic of China
&
Tianbiao Zhou1 Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People’s Republic of ChinaCorrespondence[email protected]
Pages 2179-2186 | Published online: 03 Jul 2019

References

  • Debiec H, Ronco P. Immunopathogenesis of membranous nephropathy: an update. Semin Immunopathol. 2014;36:381–397. doi:10.1007/s00281-014-0423-y24715030
  • Wasserstein AG. Membranous glomerulonephritis. J Am Soc Nephrol. 1997;8:664–674.10495797
  • Thompson A, Cattran DC, Blank M, Nachman PH. Complete and partial remission as surrogate end points in membranous nephropathy. J Am Soc Nephrol. 2015;26:2930–2937. doi:10.1681/ASN.201501009126078365
  • Chapter 7: idiopathic membranous nephropathy. Kidney Int Suppl. 2012;2:186–197. doi:10.1038/kisup.2012.20
  • Praga M, Barrio V, Juarez GF, et al. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int. 2007;71:924–930. doi:10.1038/sj.ki.500221517377504
  • Cattran DC, Appel GB, Hebert LA, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int. 2001;59:1484–1490. doi:10.1046/j.1523-1755.2001.0590041484.x11260412
  • Mccauley J, Tzakis AG, Fung JJ, et al. FK506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet. 1990;335:674. doi:10.1016/0140-6736(90)90471-g1690326
  • Shen X, Hong J, Ying M, et al. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Sci Rep. 2016;6:32087. doi:10.1038/srep3208727580845
  • Li ZQ, Hu ML, Zhang C, et al. Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: a meta-analysis of Chinese adults. J Huazhong Univ Sci Technolog Med Sci. 2015;35:623–628. doi:10.1007/s11596-015-1480-826489612
  • Chen M, Li H, Li XY, et al. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial. Am J Med Sci. 2010;339:233–238. doi:10.1097/MAJ.0b013e3181ca3a7d20220333
  • He L, Peng Y, Liu H, et al. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids. J Nephrol. 2013;26:564–571. doi:10.5301/jn.500019922956434
  • Ramachandran R, Hn HK, Kumar V, et al. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: randomized control trial. Nephrology (Carlton). 2016;21:139–146. doi:10.1111/nep.1256926205759
  • Ramachandran R, Yadav AK, Kumar V, et al. Two-year follow-up study of membranous nephropathy treated with tacrolimus and corticosteroids versus cyclical corticosteroids and cyclophosphamide. Kidney Int Rep. 2017;2:610–616. doi:10.1016/j.ekir.2017.02.00429142979
  • Westhoff TH, van der Giet M. Tacrolimus in the treatment of idiopathic nephrotic syndrome. Expert Opin Investig Drugs. 2007;16:1099–1110. doi:10.1517/13543784.16.7.1099
  • Ponticelli C, Escoli R, Moroni G. Does cyclophosphamide still play a role in glomerular diseases? Autoimmun Rev. 2018;17:1022–1027. doi:10.1016/j.autrev.2018.04.00730107267
  • Zhu LB, Liu LL, Yao L, et al. Efficacy and safety of tacrolimus versus cyclophosphamide for primary membranous nephropathy: a meta-analysis. Drugs. 2017;77:1–13. doi:10.1007/s40265-016-0675-z28005229
  • Santosh T, Hong L, Cheng LB. Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis. Chin Med J (Engl). 2014;127:2693–2699.25043091

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.